Probiotics Market

Probiotics Market Size, Share, Analysis, & Growth Trends Report by Product Type (Functional Food & Beverages (FnB), Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel and Region - Global Forecast to 2029

Report Code: FB 2269 Mar, 2024, by marketsandmarkets.com

Probiotics Market Analysis, Growth Opportunities, and Forecast (2024-2029)

Global probiotics market size is projected to grow from US$ 71.2 billion in 2024 to US$ 105.7 billion by 2029, with a CAGR of 8.2%.This growth is driven by a combination of key factors. Rising consumer awareness of gut health's link to overall well-being and a growing preference for preventive healthcare are key drivers. Additionally, innovation in delivery methods and targeted strains promises exciting future growth.

The expanding business has offered lucrative business opportunities to the players who are operating in the market segments. For instance, in October 2023, Probi (Sweden) unveiled synbiotic solutions in collaboration with Clasado (UK) at Supply Side West. Launching Bimuno GOS with Probi Defendum and Probi Digestis , these innovations signify a strategic leap into the burgeoning synbiotics sector. This milestone underscores Probi's commitment to evidence-based advancements in digestive and immune health.  Other major players, such as ADM (US), expand its international distribution partnership with Nutramax, bolstering their presence in the probiotics market. ADM Protexin now oversees Nutramax brands in Europe and select Asia Pacific markets, aiming for further global expansion. This strategic move enhances access to Nutramax's renowned pet health solutions. The deal underscores ADM's commitment to quality and animal welfare.

The overall probiotics market is classified as a fragmented market, with the Major players, namely Nestlé (Switzerland), ADM (US), International Flavors & Fragrances Inc. (US), Yakult Honsha Co., Ltd. (Japan), Meiji Holdings Co., Ltd. (Japan) occupying 12-24% of the market share.

Probiotics Market 2024 - 2029

To know about the assumptions considered for the study, Request for Free Sample Report

Probiotics Market Share

To know about the assumptions considered for the study, download the pdf brochure

Probiotics Market Dynamics

Drivers: Health benefits associated with probiotic-fortified foods

Health awareness among consumers is on the rise, wherein most consumers are constantly in search of healthy food products for daily consumption. Probiotics have provided strong health benefits, more specifically to the human digestive system. In Europe, the dairy sector is the most developed segment of the market. Probiotic yogurts and fermented milk that are sold in a convenient “daily dose and small pack” format are the most widely used. Consumer acceptance of probiotic-containing products varies greatly across Europe. For instance, in August 2021, Müller launched its first stand-alone yogurt brand in the UK called Gut Glory. The new range will be available in pack sizes of 450g and 125g packs. In addition to this, the Food and Agriculture Organization of the United Nations (FAO) has concluded the solid demand for dairy products, such as cheese and yogurts, globally. International trade in cheese products reached 2.8 million tons in 2020, sustaining the expansion for a fifth consecutive year by 4.1%, underpinned by the continued solid import demand by several countries, especially the Russian Federation, Iraq, China, and the Republic of Korea.

Restraints: High R&D costs for developing new probiotic strains

Substantial investments in research and development (R&D), alongside expenditures on laboratories, research equipment, and the hiring of skilled professionals, present formidable barriers to entry in the probiotics market. Scientific validation of probiotic applications has proven crucial for market success, with their association with health benefits posing challenges for manufacturers seeking a return on investment (RoI) given the high initial capital outlay. Leading companies such as , Probi (Sweden), Nestlé (Switzerland), ADM (US), Danone (France), and Yakult Honsha (Japan) have prioritized bolstering their R&D capabilities to secure a competitive edge, thereby erecting barriers for potential market entrants.

The development and production of probiotic strains and products adhere to international food regulations, contributing to high production costs and subsequently elevated final product prices. Marketing and distribution of probiotic products further inflate costs, as they necessitate distinct packaging and distribution channels compared to conventional products. Despite consumer awareness of the health advantages associated with probiotics, their premium pricing presents a hurdle to widespread adoption, posing a significant challenge for manufacturers.

Opportunities: Replacement of pharmaceutical agents by probiotics

The rising demand for probiotics underscores consumers' preference for products with established health benefits. As evidence of probiotics' positive impact on health continues to accumulate, consumer expectations regarding these products have grown. This trend towards seeking safe, natural, and cost-effective alternatives to pharmaceuticals has prompted the exploration of probiotics' potential as pharmaceutical agents. The efficacy of probiotics in this context appears to depend on the specific strain and dosage used. Clinical trials have demonstrated that probiotics have the potential to treat various human disorders, particularly those affecting the gastrointestinal (GI) tract. Incorporating probiotic-rich fermented dairy products into diets has shown promise in addressing specific clinical conditions, including antibiotic-associated diarrhea, rotavirus-associated diarrhea, inflammatory bowel disease, irritable bowel syndrome (IBS), allergic diseases, cancer, Helicobacter pylori infection, and lactose intolerance.

As per the research paper published by National Center for Biotechnology Information, probiotics have demonstrated high potential to treat and prevent various diseases such as neurodegenerative disorders, cancers, cardiovascular diseases, and inflammatory diseases. In addition, probiotics are also effective against multidrug-resistant pathogens and help maintain a balanced gut microbiota ecosystem.

Challenges: Complexities in integrating probiotics in functional foods

The process of developing and commercializing functional food products involves complexity, cost, and uncertainty. Success in this field depends on various factors including consumer demand, technological advancements, and regulatory frameworks. Additionally, consumer awareness of the health benefits associated with specific ingredients influences the acceptance of functional foods. While traditional functional ingredients like minerals, fiber, and vitamins remain popular, there is growing interest in novel products enriched with probiotics, prebiotics, flavonoids, carotenoids, and conjugated linolenic acid

The researcher has to work in-depth to overcome all the challenges related to the selection and development of the strain and related production processes. Probiotic strains are prone to changes in pH and temperature. The strains must sustain while integrating with functional foodstuffs. The basic requirement for probiotics is that products should contain sufficient numbers of microorganisms up to the expiry date. Hence, probiotics must contain specific strains and maintain certain numbers of live cells to produce health benefits in the host. Different countries have decided on the minimum number of viable cells required in the probiotic product for it to be beneficial. The preservation of these probiotic microorganisms presents a challenge as they are affected by exposure to temperature, oxygen, and light.

The Probiotics Market Ecosystem

Top Companies in Probiotics Market

By Product type, the Functional Food & beverages segment accounts for the highest market share Probiotics market during the forecast period.

Consumer demand for convenient and proactive wellness solutions has propelled the popularity of probiotic-fortified products like yogurts, kefir, kombucha, and fortified beverages, which offer an easy and enjoyable way to incorporate probiotics into daily routines. These products align well with the rising trend of preventive healthcare, catering to consumers seeking to maintain their health and well-being proactively. The segment benefits from continuous innovation and diversification, with manufacturers introducing a wide range of new probiotic-infused products to meet diverse taste preferences and dietary needs. This includes offerings such as probiotic-infused waters, shots, snack bars, and chocolates, catering to various consumer demographics and lifestyle choices, including vegan and lactose-free diets. As consumers increasingly seek personalized solutions for their health concerns, the segment is poised to further expand through tailored probiotic formulations designed to address specific digestive issues or mental health concerns, emphasizing the importance of personalization in driving market growth

Probiotics Market by Segmentation

By Ingredient, the bacteria segment accounts for a significant market share in the Probiotics market.

Bacteria have a well-established reputation and extensive scientific backing supporting their efficacy in promoting gut health, a fundamental application of probiotics. Bacterial strains offer a broader spectrum of diversity compared to alternative probiotic types like yeast, enabling the development of targeted formulations tailored to address specific health needs. Recent innovations, such as psychobiotic strains targeting mental well-being and spore-forming bacteria with improved shelf life and delivery properties, underscore the versatility and applicability of bacterial probiotics. The established and cost-effective manufacturing processes associated with bacteria contribute to greater affordability and broader consumer accessibility, further consolidating the bacteria segment's market dominance during the forecasted period.

By Distribution channel, the Hypermarkets/ Supermarkets segment accounts for a significant market share in the Probiotics market.

Hypermarkets, comprising expansive supermarkets and warehouse clubs, stand as pivotal hubs for probiotic distribution, capitalizing on their extensive reach and accessibility. With a sprawling network of stores, hypermarkets offer unparalleled convenience to a broad spectrum of consumers, ensuring easy access to probiotic products. This accessibility is especially important for those who prioritize convenience and don't often visit specialty stores. Moreover, hypermarkets provide a comprehensive shopping experience by curating a diverse selection of groceries, including a dedicated health and wellness section where probiotics are prominently featured. This one-stop shopping approach streamlines the purchasing process for consumers, allowing them to fulfill their dietary needs alongside other household essentials. The abundant product variety available at hypermarkets, spanning different brands, formulations, and price points, further caters to diverse consumer preferences, enriching the shopping experience.

By End User, the Human segment accounts for a significant market share in the Probiotics market.

This segment benefits from a multifaceted approach that encompasses growing awareness of gut health among the public, underscored by a 2022 IFIC survey revealing that 24% of respondents prioritize digestive health in their overall well-being. Additionally, with 32% of respondents actively seeking out probiotics and 60% of those consumers integrating them into their daily routine, there is a palpable demand for probiotic products tailored to human health needs, including digestive support, immune enhancement, and mental well-being. Furthermore, the human probiotics market thrives on a continuous stream of product innovation, evidenced by the emergence of personalized formulations targeting specific health concerns and innovative delivery methods such as chewable tablets. This innovative spirit extends to exploring psychobiotic strains for mental health benefits, highlighting the dynamic nature of the market.

Increased awareness of gut microbiome and aging population are key drivers in Asia-Pacific probiotics market. Asia Pacific is poised to experience the highest CAGR in the Probiotics market during the forecast period.

An increased awareness of the gut microbiome and its profound impact on digestion, immunity, and mental health among the public. This heightened awareness is prompting individuals to explore probiotic supplements and foods fortified with probiotics as a means to support overall well-being. Additionally, the region's rapidly aging population, particularly in countries like South Korea, is driving the adoption of probiotics, as they are increasingly recognized for their potential benefits for gut health and immune function in older adults. Innovation, such as the development of personalized probiotic strains tailored to individual health needs, and exploration into probiotics for skin health and mental well-being, is expected to further amplify market potential in the region. In  December 2020 government initiatives, such as India's promotion of nutraceuticals through policies such as the AYUSH policy, are also fostering market growth. With these factors at play, the Asia Pacific region is poised to experience the highest CAGR in the probiotics market during the forecast period.

Asia Pacific: Probiotics Market Snapshot

Probiotics Market Trends, Region

Key Market Players

Key players in this market include Probi (Sweden), Nestlé (Switzerland), ADM (US), Danone (France), International Flavors & Fragrances Inc. (US), Yakult Honsha Co., Ltd. (Japan), BioGaia (Sweden), MORINAGA MILK INDUSTRY CO., LTD. (Japan), Meiji Holdings Co., Ltd. (Japan), Lifeway Foods, Inc. (US), Adisseo (France), Winclove Probiotics (US), AB-Biotics, S.A. (Belgium), Apsen Farmacêutica (Brazil), and Lallemand (Canada).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size estimation

2024–2029

Base year considered

2023

Forecast period considered

2024–2029

Units considered

Value (USD), Volume (KT)

Segments Covered

Product type, ingredient, distribution channel, end user, and region.

Regions covered

North America, Europe, Asia Pacific, South America, and Rest of the World

Companies studied

  • Probi (Sweden)
  • Nestlé (Switzerland)
  • ADM (US)
  • Danone (France)
  • International Flavors & Fragrances Inc. (US)
  • Yakult Honsha Co., Ltd. (Japan)
  • BioGaia (Sweden)
  • MORINAGA MILK INDUSTRY CO., LTD. (Japan)
  • Meiji Holdings Co., Ltd. (Japan)
  • Lifeway Foods, Inc. (US)
  • Adisseo (France)
  • Winclove Probiotics (US)
  • AB-Biotics, S.A. (Belgium)
  • Apsen Farmacêutica (Brazil)
  • Lallemand (Canada)
  • Elanco (US)
  • NextFoods, Inc.(US)
  • i-Health, Inc. (US)
  • Suja Life LLC. (US)
  • Renew Life Formulas LLC. (US)
  • BIOHM Health (US)
  • Sun Genomics (US)
  • Unique Biotech Ltd (India)
  • So Good So You (US)
  • Protocol For Life Balance (US)

Report Scope:

Probiotics market:

By Product Type
  • Functional Food & Beverages
    • Dairy Products
    • Non-Dairy Beverage
    • Infant Formula
    • Cereals
    • Other Applications
  • Dietary Supplements
    • Tablets
    • Capsules
    • Powders
    • Liquids
    • Soft Gels
    • Gel Caps
  • Feed
By Ingredient
  • Bacteria
    • Lactobacilli
      • Lactobacillus Acidophilus
      • Lactobacillus Rhamnosus
      • Lactobacillus Casei
      • Lactobacillus Reuteri
    • Bifidobacterium                       
    • Streptococcus Thermophilus                              
  • Yeast
    • Saccharomyces Boulardii                      
    • Other Yeasts             
By Distribution Channel
  • Hypermarkets/Supermarkets
  • Pharmacies/Drugstores
  • Specialty Stores
  • Online
  • Convenience Stores/Small Retail Formats     
By End User
  • Human
  • Animal
By Region
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Rest of the World

Key Probiotics Industry Developments

  • In February 2024, AB Biotics SA (Netherlands) expands its presence in Asia, partnering with Wonderlab for their globally marketed product, AB-LIFE . The collaboration introduces Shape100 , a probiotic blend focusing on cardiometabolic health, to the Chinese market. This strategic move aims to address cholesterol-related concerns through evidence-based solutions.
  • In November 2023, Nestlé (Switzerland) launched N3 milk, a breakthrough in nutritional innovation. Incorporating prebiotic fibers and reduced lactose, it enriches gut health and boasts over 15% fewer calories. Tailored for diverse dietary needs, N3 supports bone health, muscle growth, and immunity.
  • In September 2023, Yakult Honsha Co Ltd (Japan) Introduced the Yakult Gohonmaru Cafe & Gallery in Utsunomiya, Japan. This innovative venture, inclusive of a beauty salon and gallery, offers patrons an array of delectable treats infused with Yakult probiotic beverage. The strategic investment underscores Yakult's commitment to expanding its consumer base and fostering brand awareness.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 28)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
    1.3 STUDY SCOPE 
           1.3.1 MARKET SEGMENTATION
           1.3.2 INCLUSIONS AND EXCLUSIONS
           1.3.3 REGIONS COVERED
           1.3.4 YEARS CONSIDERED
    1.4 UNITS CONSIDERED 
           1.4.1 CURRENCY (VALUE UNIT)
           1.4.2 VOLUME UNIT
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
    1.7 RECESSION IMPACT ANALYSIS 
 
2 RESEARCH METHODOLOGY (Page No. - 35)
    2.1 RESEARCH DATA 
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key primary insights
                    2.1.2.2 Breakdown of Primary Interviews
    2.2 MARKET SIZE ESTIMATION 
           2.2.1 BOTTOM-UP APPROACH
           2.2.2 TOP-DOWN APPROACH
                    2.2.2.1 Supply side analysis
    2.3 DATA TRIANGULATION 
    2.4 RESEARCH ASSUMPTIONS 
    2.5 RESEARCH LIMITATIONS 
    2.6 RECESSION IMPACT ON PROBIOTICS MARKET 
           2.6.1 RECESSION MACROECONOMIC INDICATORS
 
3 EXECUTIVE SUMMARY (Page No. - 49)
 
4 PREMIUM INSIGHTS (Page No. - 54)
    4.1 ATTRACTIVE OPPORTUNITIES IN PROBIOTICS MARKET 
    4.2 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE AND COUNTRY 
    4.3 PROBIOTICS MARKET, BY PRODUCT TYPE 
    4.4 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY-PRODUCT SUBTYPE 
    4.5 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL 
    4.6 PROBIOTICS MARKET, BY END USER 
    4.7 PROBIOTICS MARKET, BY INGREDIENT 
 
5 MARKET OVERVIEW (Page No. - 58)
    5.1 INTRODUCTION 
    5.2 MACROECONOMIC INDICATORS 
           5.2.1 INCREASE IN RETAIL SALES
           5.2.2 GROWTH OPPORTUNITIES IN DEVELOPING REGIONS SUCH AS ASIA PACIFIC AND SOUTH AMERICA
    5.3 MARKET DYNAMICS 
           5.3.1 DRIVERS
                    5.3.1.1 Rise in awareness on health benefits associated with probiotic-fortified foods
                    5.3.1.2 Participation of international bodies in R&D of probiotic products
                    5.3.1.3 Technological advancements in probiotic products
           5.3.2 RESTRAINTS
                    5.3.2.1 High R&D costs for developing new probiotic strains
                    5.3.2.2 Instances of allergic reactions to some probiotic supplements
                    5.3.2.3 Stress factors affecting probiotic efficacy
           5.3.3 OPPORTUNITIES
                    5.3.3.1 Ban on use of Antibiotic Growth Promoters (AGPs) in feed in EU
                    5.3.3.2 Replacement of pharmaceutical agents by probiotics
                    5.3.3.3 Use of yeast probiotics as antibiotics or growth promoters
           5.3.4 CHALLENGES
                    5.3.4.1 Complexities in integrating probiotics in functional foods
                    5.3.4.2 Intolerance of probiotics to stomach acid and bile
 
6 INDUSTRY TRENDS (Page No. - 66)
    6.1 INTRODUCTION 
    6.2 VALUE CHAIN ANALYSIS 
           6.2.1 RESEARCH & PRODUCT DEVELOPMENT
           6.2.2 SOURCING
           6.2.3 PRODUCTION & PROCESSING
           6.2.4 PACKAGING & STORAGE
           6.2.5 DISTRIBUTION, SALES, AND MARKETING
    6.3 SUPPLY CHAIN ANALYSIS 
    6.4 TECHNOLOGY ANALYSIS 
           6.4.1 KEY TECHNOLOGIES
                    6.4.1.1 Multi-layer embedding
                    6.4.1.2 Microencapsulated powder for probiotication in food products
           6.4.2 COMPLEMENTARY TECHNOLOGY
                    6.4.2.1 Probiotics and artificial intelligence
    6.5 PRICING ANALYSIS 
           6.5.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY FUNCTIONAL FOOD & BEVERAGES
           6.5.2 AVERAGE SELLING PRICE TREND, BY PRODUCT TYPE
    6.6 ECOSYSTEM ANALYSIS/MARKET MAP 
           6.6.1 SUPPLY-SIDE ANALYSIS
           6.6.2 DEMAND SIDE ANALYSIS
    6.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 
    6.8 TRADE DATA ANALYSIS 
    6.9 PATENT ANALYSIS 
    6.1 KEY CONFERENCES & EVENTS 
    6.11 REGULATORY LANDSCAPE 
           6.11.1 PERTINENT REGULATORY FACTORS
                    6.11.1.1 North america
                               6.11.1.1.1 US
                               6.11.1.1.2 Canada
                    6.11.1.2 Europe
                    6.11.1.3 Asia pacific
                               6.11.1.3.1 Japan
                               6.11.1.3.2 Australia and New Zealand
                               6.11.1.3.3 India
                    6.11.1.4 South america
                               6.11.1.4.1 Brazil
                    6.11.1.5 Row
                               6.11.1.5.1 Middle East
                               6.11.1.5.2 Africa (South Africa)
           6.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
    6.12 PORTER’S FIVE FORCES ANALYSIS 
           6.12.1 THREAT OF NEW ENTRANTS
           6.12.2 THREAT OF SUBSTITUTES
           6.12.3 BARGAINING POWER OF SUPPLIERS
           6.12.4 BARGAINING POWER OF BUYERS
           6.12.5 INTENSITY OF COMPETITIVE RIVALRY
    6.13 CASE STUDIES 
           6.13.1 ADM: PROMOTED METABOLIC HEALTH WITH BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS CECT 8145 BPL1
           6.13.2 MAGNITUDE BIOSCIENCES AND AB BIOTEK HNH: PROBIOTIC DEVELOPMENT WITH ETHICAL AND HIGH-THROUGHPUT TESTING
    6.14 KEY STAKEHOLDERS AND BUYING CRITERIA 
           6.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
           6.14.2 BUYING CRITERIA
    6.15 INVESTMENT AND FUNDING SCENARIO 
 
7 PROBIOTICS MARKET, BY PRODUCT TYPE (Page No. - 94)
    7.1 INTRODUCTION 
    7.2 FUNCTIONAL FOOD & BEVERAGES 
           7.2.1 DAIRY PRODUCTS
                    7.2.1.1 Popularity of dairy products and high compatibility with probiotics
           7.2.2 NONDAIRY BEVERAGES
                    7.2.2.1 Need to cater to increasing lactose-intolerant consumers
           7.2.3 INFANT FORMULA
                    7.2.3.1 Rise in consumption of fortified infant nutrition
           7.2.4 CEREALS
                    7.2.4.1 Rise in demand for ready-to-eat food items with changing consumer lifestyles
           7.2.5 OTHER FUNCTIONAL FOOD & BEVERAGES
    7.3 DIETARY SUPPLEMENTS 
           7.3.1 TABLETS
                    7.3.1.1 High shelf-life, affordability, and wide range of dosage patterns
           7.3.2 CAPSULES
                    7.3.2.1 Rapid absorption of nutrients and highly customizable
           7.3.3 POWDERS
                    7.3.3.1 Easy release of active ingredients and high stability
           7.3.4 LIQUIDS
                    7.3.4.1 Easy consumption, greater homogeneity, and high absorption in bloodstreams
           7.3.5 SOFT GELS
                    7.3.5.1 Relatively low cost and improved bioavailability
           7.3.6 GEL CAPS
                    7.3.6.1 Pure-protein, benign oral dosage form
    7.4 FEED 
           7.4.1 RISE IN TREND FOR PROVIDING PETS WITH HIGH-QUALITY AND HEALTHY WET AND DRY MEALS
 
8 PROBIOTICS MARKET, BY INGREDIENT (Page No. - 111)
    8.1 INTRODUCTION 
    8.2 BACTERIA 
           8.2.1 LACTOBACILLI
                    8.2.1.1 Lactobacillus acidophilus
                               8.2.1.1.1 Rise in consumption of fermented foods, cheese, and yogurt
                    8.2.1.2 Lactobacillus rhamnosus
                               8.2.1.2.1 Ability to endure harsh gut conditions and reduced risk of antibiotic-associated intestinal symptoms
                    8.2.1.3 Lactobacillus casei
                               8.2.1.3.1 Broad-spectrum action against diseases caused by gastrointestinal pathogenic bacteria
                    8.2.1.4 Lactobacillus reuteri
                               8.2.1.4.1 Opportunities in preventive and therapeutic avenues against inflammatory diseases
           8.2.2 BIFIDOBACTERIUM
                    8.2.2.1 Benefits against chronic ailments, especially in infant gut health
           8.2.3 STREPTOCOCCUS THERMOPHILUS
                    8.2.3.1 Growing application of Streptococcus thermophilus in food and feed industries
    8.3 YEAST 
           8.3.1 SACCHAROMYCES BOULARDII
                    8.3.1.1 GI stress-resistance key in maintaining gut flora balance
           8.3.2 OTHER YEASTS
 
9 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL (Page No. - 125)
    9.1 INTRODUCTION 
    9.2 HYPERMARKETS/SUPERMARKETS 
           9.2.1 EXPANSION OF SUPERMARKETS IN ASIA PACIFIC
    9.3 PHARMACIES/DRUGSTORES 
           9.3.1 RISE IN AWARENESS FOR PROBIOTIC SUPPLEMENTS IN DEVELOPED COUNTRIES TO POPULARIZE PHARMACIES
    9.4 SPECIALTY STORES 
           9.4.1 PROBIOTIC SALES FUELED BY PROPER STORAGE AND TRANSPARENT LABELING
    9.5 ONLINE 
           9.5.1 ONLINE SALES SURGE DUE TO CONVENIENCE, HEALTH FOCUS, AND STRONG BRAND LOYALTY AMONG CONSUMERS
    9.6 CONVENIENCE STORES/SMALL RETAIL FORMATS 
           9.6.1 EASY ACCESS FOR CONSUMERS ENCOURAGING PURCHASE
 
10 PROBIOTICS MARKET, BY END USER (Page No. - 133)
     10.1 INTRODUCTION 
     10.2 HUMAN 
             10.2.1 RISING TREND OF CONSUMING FUNCTIONAL FOODS DUE TO HEALTH CONSCIOUSNESS
     10.3 ANIMAL 
             10.3.1 BAN ON SYNTHETIC ANTIBIOTICS TO BOOST MARKET IN FEED
 
11 PROBIOTICS MARKET, BY REGION (Page No. - 140)
     11.1 INTRODUCTION 
     11.2 NORTH AMERICA 
             11.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS
             11.2.2 US
                       11.2.2.1 Rise in digestive health awareness
             11.2.3 CANADA
                       11.2.3.1 Demand for high-quality and innovative feed products to accelerate probiotics production and consumption
             11.2.4 MEXICO
                       11.2.4.1 Consumer inclination toward healthy diets
     11.3 EUROPE 
             11.3.1 EUROPE: RECESSION IMPACT ANALYSIS
             11.3.2 RUSSIA
                       11.3.2.1 Highly regulated probiotic landscape
             11.3.3 UK
                       11.3.3.1 Shift toward natural foods that support digestive health
             11.3.4 ITALY
                       11.3.4.1 Preference for cheese and awareness about health benefits of probiotics
             11.3.5 GERMANY
                       11.3.5.1 Preference for probiotic yogurts and yogurt drinks and opportunity for use in poultry feed
             11.3.6 SPAIN
                       11.3.6.1 Growing interest in health and wellness products among consumers to spur investment by companies
             11.3.7 REST OF EUROPE
     11.4 ASIA PACIFIC 
             11.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS
             11.4.2 CHINA
                       11.4.2.1 Strategic moves by players to tap high sales potential of probiotics
             11.4.3 JAPAN
                       11.4.3.1 Focus on digestive well-being of aging population
             11.4.4 INDIA
                       11.4.4.1 Increased focus on women’s nutrition and post-COVID-19 consumer preference for functional food
             11.4.5 AUSTRALIA & NEW ZEALAND
                       11.4.5.1 Aging population and consumer awareness to drive clinical trials and retail sales
             11.4.6 REST OF ASIA PACIFIC
     11.5 SOUTH AMERICA 
             11.5.1 SOUTH AMERICA: RECESSION IMPACT ANALYSIS
             11.5.2 BRAZIL
                       11.5.2.1 Rise in health awareness and meat exports to EU
             11.5.3 ARGENTINA
                       11.5.3.1 Increase in industrialization of meat processing and dairy productivity
             11.5.4 REST OF SOUTH AMERICA
     11.6 REST OF THE WORLD (ROW) 
             11.6.1 ROW: RECESSION IMPACT ANALYSIS
             11.6.2 MIDDLE EAST
                       11.6.2.1 Demand for quality feed, high consumption of feed, and demand for yogurt
             11.6.3 AFRICA
                       11.6.3.1 Investments in pharmaceutical companies to increase with intra-African trade
 
12 COMPETITIVE LANDSCAPE (Page No. - 196)
     12.1 OVERVIEW 
     12.2 KEY PLAYERS’ STRATEGIES/RIGHT TO WIN 
     12.3 REVENUE ANALYSIS 
     12.4 MARKET SHARE ANALYSIS 
     12.5 COMPANY VALUATION AND FINANCIAL METRICS 
     12.6 BRAND/PRODUCT COMPARISON 
             12.6.1 DIVERSE PROBIOTIC SOLUTIONS FUELING MARKET GROWTH
                       12.6.1.1 Nestlé Cerelac
                       12.6.1.2 Danone’s Activia
                       12.6.1.3 Yakult
                       12.6.1.4 LG21 by Meiji Holding Inc.
                       12.6.1.5 HOWARU by IFF Health
     12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             12.7.1 STARS
             12.7.2 EMERGING LEADERS
             12.7.3 PERVASIVE PLAYERS
             12.7.4 PARTICIPANTS
             12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                       12.7.5.1 Company footprint
                       12.7.5.2 Product type footprint
                       12.7.5.3 End user footprint
                       12.7.5.4 Region footprint
     12.8 COMPANY EVALUATION MATRIX: STARTUP/SMES, 2023 
             12.8.1 PROGRESSIVE COMPANIES
             12.8.2 RESPONSIVE COMPANIES
             12.8.3 DYNAMIC COMPANIES
             12.8.4 STARTING BLOCKS
             12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES
                       12.8.5.1 Detailed list of key startup/smes
                       12.8.5.2 Competitive benchmarking of key startup/SMEs
     12.9 COMPETITIVE SCENARIO AND TRENDS 
             12.9.1 PRODUCT LAUNCHES
             12.9.2 DEALS
             12.9.3 OTHERS
 
13 COMPANY PROFILES (Page No. - 233)
     13.1 KEY PLAYERS 
             13.1.1 PROBI
                       13.1.1.1 Business overview
                       13.1.1.2 Products/Services/Solutions offered
                       13.1.1.3 Recent developments
                                   13.1.1.3.1 Product launches
                                   13.1.1.3.2 Deals
                       13.1.1.4 MnM view
                                   13.1.1.4.1 Key strengths
                                   13.1.1.4.2 Strategic choices made
                                   13.1.1.4.3 Weaknesses and competitive threats
             13.1.2 NESTLÉ
                       13.1.2.1 Business overview
                       13.1.2.2 Products/Services/Solutions offered
                       13.1.2.3 Recent developments
                                   13.1.2.3.1 Product launches
                                   13.1.2.3.2 Deals
                       13.1.2.4 MnM view
                                   13.1.2.4.1 Key strengths
                                   13.1.2.4.2 Strategic choices made
                                   13.1.2.4.3 Weaknesses and competitive threats
             13.1.3 ADM
                       13.1.3.1 Business overview
                       13.1.3.2 Products/Services/Solutions offered
                       13.1.3.3 Recent developments
                                   13.1.3.3.1 Deals
                                   13.1.3.3.2 Others
                       13.1.3.4 MnM view
                                   13.1.3.4.1 Key strengths
                                   13.1.3.4.2 Strategic choices made
                                   13.1.3.4.3 Weaknesses and competitive threats
             13.1.4 DANONE
                       13.1.4.1 Business overview
                       13.1.4.2 Products/Services/Solutions offered
                       13.1.4.3 Recent developments
                                   13.1.4.3.1 Product launches
                                   13.1.4.3.2 Others
                       13.1.4.4 MnM view
                                   13.1.4.4.1 Key strengths
                                   13.1.4.4.2 Strategic choices made
                                   13.1.4.4.3 Weaknesses and competitive threats
             13.1.5 INTERNATIONAL FLAVORS & FRAGRANCES INC.
                       13.1.5.1 Business overview
                       13.1.5.2 Products/Services/Solutions offered
                       13.1.5.3 Recent developments
                                   13.1.5.3.1 Deals
                                   13.1.5.3.2 Others
                       13.1.5.4 MnM view
                                   13.1.5.4.1 Key strengths
                                   13.1.5.4.2 Strategic choices made
                                   13.1.5.4.3 Weaknesses and competitive threats
             13.1.6 YAKULT HONSHA CO., LTD.
                       13.1.6.1 Business overview
                       13.1.6.2 Products/Services/Solutions offered
                       13.1.6.3 Recent developments
                                   13.1.6.3.1 Product launches
                                   13.1.6.3.2 Deals
                                   13.1.6.3.3 Others
                       13.1.6.4 MnM view
             13.1.7 BIOGAIA
                       13.1.7.1 Business overview
                       13.1.7.2 Products/Services/Solutions offered
                       13.1.7.3 Recent developments
                                   13.1.7.3.1 Product launches
                                   13.1.7.3.2 Deals
                                   13.1.7.3.3 Others
                       13.1.7.4 MnM view
             13.1.8 MORINAGA MILK INDUSTRY CO., LTD.
                       13.1.8.1 Business overview
                       13.1.8.2 Products/Services/Solutions offered
                       13.1.8.3 Recent developments
                                   13.1.8.3.1 Product launches
                                   13.1.8.3.2 Others
                       13.1.8.4 MnM view
             13.1.9 MEIJI HOLDINGS CO., LTD.
                       13.1.9.1 Business overview
                       13.1.9.2 Products/Services/Solutions offered
                       13.1.9.3 Recent developments
                       13.1.9.4 MnM view
               13.1.10 LIFEWAY FOODS, INC.
            13.1.10.1 Business overview
            13.1.10.2 Products/Services/Solutions offered
            13.1.10.3 Recent developments
                     13.1.10.3.1 Deals
            13.1.10.4 MnM view
               13.1.11 ADISSEO
            13.1.11.1 Business overview
            13.1.11.2 Products/Services/Solutions offered
            13.1.11.3 Recent developments
            13.1.11.4 MnM view
               13.1.12 WINCLOVE PROBIOTICS
            13.1.12.1 Business overview
            13.1.12.2 Products/Services/Solutions offered
            13.1.12.3 Recent developments
                     13.1.12.3.1 Deals
                     13.1.12.3.2 Others
            13.1.12.4 MnM view
               13.1.13 AB-BIOTICS, S.A.
            13.1.13.1 Business overview
            13.1.13.2 Products/Services/Solutions offered
            13.1.13.3 Recent developments
                     13.1.13.3.1 Deals
            13.1.13.4 MnM view
               13.1.14 APSEN FARMACÊUTICA
            13.1.14.1 Business overview
            13.1.14.2 Products/Services/Solutions offered
            13.1.14.3 Recent developments
                     13.1.14.3.1 Product launches
                     13.1.14.3.2 Deals
            13.1.14.4 MnM view
               13.1.15 LALLEMAND
            13.1.15.1 Business overview
            13.1.15.2 Products/Services/Solutions offered
            13.1.15.3 Recent developments
                     13.1.15.3.1 Deals
                     13.1.15.3.2 Others
            13.1.15.4 MnM view
     13.2 STARTUP/SME PLAYERS 
             13.2.1 ELANCO
                       13.2.1.1 Business overview
                       13.2.1.2 Products/Services/Solutions offered
                       13.2.1.3 Recent developments
                       13.2.1.4 MnM view
             13.2.2 NEXTFOODS, INC.
                       13.2.2.1 Business overview
                       13.2.2.2 Products/Services/Solutions offered
                       13.2.2.3 Recent developments
                                   13.2.2.3.1 Deals
                       13.2.2.4 MnM view
             13.2.3 I-HEALTH, INC.
                       13.2.3.1 Business overview
                       13.2.3.2 Products/Services/Solutions offered
                       13.2.3.3 Recent developments
                       13.2.3.4 MnM view
             13.2.4 SUJA LIFE, LLC.
                       13.2.4.1 Business overview
                       13.2.4.2 Products/Services/Solutions offered
                       13.2.4.3 Recent developments
                                   13.2.4.3.1 Deals
                       13.2.4.4 MnM view
             13.2.5 RENEW LIFE FORMULAS, LLC
                       13.2.5.1 Business overview
                       13.2.5.2 Products/Services/Solutions offered
                       13.2.5.3 Recent developments
                       13.2.5.4 MnM view
             13.2.6 BIOHM HEALTH
             13.2.7 SUN GENOMICS
             13.2.8 UNIQUE BIOTECH LTD
             13.2.9 SO GOOD SO YOU
               13.2.10 PROTOCOL FOR LIFE BALANCE
 
14 ADJACENT AND RELATED MARKETS (Page No. - 333)
     14.1 INTRODUCTION 
     14.2 RESEARCH LIMITATIONS 
     14.3 DIETARY SUPPLEMENT MARKET 
             14.3.1 MARKET DEFINITION
             14.3.2 MARKET OVERVIEW
     14.4 BONE & JOINT HEALTH SUPPLEMENTS MARKET 
             14.4.1 MARKET DEFINITION
             14.4.2 MARKET OVERVIEW
 
15 APPENDIX (Page No. - 337)
     15.1 DISCUSSION GUIDE 
     15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     15.3 CUSTOMIZATION OPTIONS 
     15.4 RELATED REPORTS 
     15.5 AUTHOR DETAILS 
 
 
LIST OF TABLES (266 Tables)
 
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2019–2022
TABLE 2 PROBIOTICS MARKET SNAPSHOT, 2024 VS. 2029
TABLE 3 PROBIOTICS MARKET: SUPPLY CHAIN (ECOSYSTEM)
TABLE 4 EXPORT SCENARIO FOR HS CODE 300290, BY COUNTRY, 2021–2023 (KG)
TABLE 5 IMPORT SCENARIO FOR HS CODE 300290, BY COUNTRY, 2021–2023 (KG)
TABLE 6 KEY PATENTS IN PROBIOTICS MARKET, 2023–2024
TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 PROBIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 11 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP THREE PRODUCT TYPES
TABLE 12 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS, BY PRODUCT TYPE
TABLE 13 PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION)
TABLE 14 PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION)
TABLE 15 PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT)
TABLE 16 PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT)
TABLE 17 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2020–2023 (USD BILLION)
TABLE 18 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2024–2029 (USD BILLION)
TABLE 19 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2020–2023 (KT)
TABLE 20 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2024–2029 (KT)
TABLE 21 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION)
TABLE 22 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION)
TABLE 23 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2020–2023 (USD BILLION)
TABLE 24 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2024–2029 (USD BILLION)
TABLE 25 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2020–2023 (KT)
TABLE 26 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2024–2029 (KT)
TABLE 27 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION)
TABLE 28 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION)
TABLE 29 PROBIOTICS MARKET IN FEED, BY REGION, 2020–2023 (USD BILLION)
TABLE 30 PROBIOTICS MARKET IN FEED, BY REGION, 2024–2029 (USD BILLION)
TABLE 31 PROBIOTICS MARKET IN FEED, BY REGION, 2020–2023 (KT)
TABLE 32 PROBIOTICS MARKET IN FEED, BY REGION, 2024–2029 (KT)
TABLE 33 DIVERSITY OF PROBIOTICS
TABLE 34 HEALTH BENEFITS OF PROBIOTIC MICROORGANISMS
TABLE 35 PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION)
TABLE 36 PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION)
TABLE 37 BACTERIAL PROBIOTICS MARKET, BY REGION, 2020–2023 (USD BILLION)
TABLE 38 BACTERIAL PROBIOTICS MARKET, BY REGION, 2024–2029 (USD BILLION)
TABLE 39 BACTERIAL PROBIOTICS MARKET, BY TYPE, 2020–2023 (USD BILLION)
TABLE 40 BACTERIAL PROBIOTICS MARKET, BY TYPE, 2024–2029 (USD BILLION)
TABLE 41 YEAST-BASED PROBIOTICS MARKET, BY REGION, 2020–2023 (USD BILLION)
TABLE 42 YEAST-BASED PROBIOTICS MARKET, BY REGION, 2024–2029 (USD BILLION)
TABLE 43 YEAST-BASED PROBIOTICS MARKET, BY TYPE, 2020–2023 (USD BILLION)
TABLE 44 YEAST-BASED PROBIOTICS MARKET, BY TYPE, 2024–2029 (USD BILLION)
TABLE 45 BENEFICIAL EFFECTS OF YEAST
TABLE 46 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION)
TABLE 47 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION)
TABLE 48 PROBIOTICS MARKET IN HYPERMARKETS/SUPERMARKETS, BY REGION, 2020–2023 (USD BILLION)
TABLE 49 PROBIOTICS MARKET IN HYPERMARKETS/SUPERMARKETS, BY REGION, 2024–2029 (USD BILLION)
TABLE 50 PROBIOTICS MARKET IN PHARMACIES/DRUGSTORES, BY REGION, 2020–2023 (USD BILLION)
TABLE 51 PROBIOTICS MARKET IN PHARMACIES/DRUGSTORES, BY REGION, 2024–2029 (USD BILLION)
TABLE 52 PROBIOTICS MARKET IN SPECIALTY STORES, BY REGION, 2020–2023 (USD BILLION)
TABLE 53 PROBIOTICS MARKET IN SPECIALTY STORES, BY REGION, 2024–2029 (USD BILLION)
TABLE 54 PROBIOTICS MARKET IN ONLINE CHANNELS, BY REGION, 2020–2023 (USD BILLION)
TABLE 55 PROBIOTICS MARKET IN ONLINE CHANNELS, BY REGION, 2024–2029 (USD BILLION)
TABLE 56 PROBIOTICS MARKET IN CONVENIENCE STORES/SMALL RETAIL FORMATS, BY REGION, 2020–2023 (USD BILLION)
TABLE 57 PROBIOTICS MARKET IN CONVENIENCE STORES/SMALL RETAIL FORMATS, BY REGION, 2024–2029 (USD BILLION)
TABLE 58 PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION)
TABLE 59 PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION)
TABLE 60 PROBIOTICS MARKET FOR HUMAN USE, BY REGION, 2020–2023 (USD BILLION)
TABLE 61 PROBIOTICS MARKET FOR HUMAN USE, BY REGION, 2024–2029 (USD BILLION)
TABLE 62 BENEFITS ASSOCIATED WITH ADMINISTRATION OF PROBIOTICS IN ANIMAL FEED
TABLE 63 PROBIOTICS MARKET FOR ANIMAL USE, BY REGION, 2020–2023 (USD BILLION)
TABLE 64 PROBIOTICS MARKET FOR ANIMAL USE, BY REGION, 2024–2029 (USD BILLION)
TABLE 65 PROBIOTICS MARKET, BY REGION, 2020–2023 (USD BILLION)
TABLE 66 PROBIOTICS MARKET, BY REGION, 2024–2029 (USD BILLION)
TABLE 67 PROBIOTICS MARKET, BY REGION, 2020–2023 (KT)
TABLE 68 PROBIOTICS MARKET, BY REGION, 2024–2029 (KT)
TABLE 69 NORTH AMERICA: PROBIOTICS MARKET, BY COUNTRY, 2020–2023 (USD BILLION)
TABLE 70 NORTH AMERICA: PROBIOTICS MARKET, BY COUNTRY, 2024–2029 (USD BILLION)
TABLE 71 NORTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION)
TABLE 72 NORTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION)
TABLE 73 NORTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT)
TABLE 74 NORTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT)
TABLE 75 NORTH AMERICA: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION)
TABLE 76 NORTH AMERICA: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION)
TABLE 77 NORTH AMERICA: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION)
TABLE 78 NORTH AMERICA: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION)
TABLE 79 NORTH AMERICA: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION)
TABLE 80 NORTH AMERICA: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION)
TABLE 81 NORTH AMERICA: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION)
TABLE 82 NORTH AMERICA: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION)
TABLE 83 US: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 84 US: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
TABLE 85 CANADA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 86 CANADA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
TABLE 87 MEXICO: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 88 MEXICO: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
TABLE 89 EUROPE: PROBIOTICS MARKET, BY COUNTRY, 2020–2023 (USD BILLION)
TABLE 90 EUROPE: PROBIOTICS MARKET, BY COUNTRY, 2024–2029 (USD BILLION)
TABLE 91 EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION)
TABLE 92 EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION)
TABLE 93 EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT)
TABLE 94 EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT)
TABLE 95 EUROPE: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION)
TABLE 96 EUROPE: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION)
TABLE 97 EUROPE: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION)
TABLE 98 EUROPE: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION)
TABLE 99 EUROPE: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION)
TABLE 100 EUROPE: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION)
TABLE 101 EUROPE: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION)
TABLE 102 EUROPE: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION)
TABLE 103 RUSSIA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 104 RUSSIA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
TABLE 105 UK: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 106 UK: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
TABLE 107 ITALY: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 108 ITALY: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
TABLE 109 GERMANY: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 110 GERMANY: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
TABLE 111 SPAIN: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 112 SPAIN: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
TABLE 113 REST OF EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 114 REST OF EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
TABLE 115 ASIA PACIFIC: PROBIOTICS MARKET, BY COUNTRY/REGION, 2020–2023 (USD BILLION)
TABLE 116 ASIA PACIFIC: PROBIOTICS MARKET, BY COUNTRY/REGION, 2024–2029 (USD BILLION)
TABLE 117 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION)
TABLE 118 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION)
TABLE 119 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT)
TABLE 120 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT)
TABLE 121 ASIA PACIFIC: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION)
TABLE 122 ASIA PACIFIC: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION)
TABLE 123 ASIA PACIFIC: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION)
TABLE 124 ASIA PACIFIC: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION)
TABLE 125 ASIA PACIFIC: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION)
TABLE 126 ASIA PACIFIC: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION)
TABLE 127 ASIA PACIFIC: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION)
TABLE 128 ASIA PACIFIC: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION)
TABLE 129 CHINA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 130 CHINA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
TABLE 131 JAPAN: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 132 JAPAN: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
TABLE 133 INDIA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 134 INDIA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
TABLE 135 AUSTRALIA & NEW ZEALAND: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 136 AUSTRALIA & NEW ZEALAND: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
TABLE 137 REST OF ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 138 REST OF ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
TABLE 139 SOUTH AMERICA: PROBIOTICS MARKET, BY COUNTRY, 2020–2023 (USD BILLION)
TABLE 140 SOUTH AMERICA: PROBIOTICS MARKET, BY COUNTRY, 2024–2029 (USD BILLION)
TABLE 141 SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION)
TABLE 142 SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION)
TABLE 143 SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT)
TABLE 144 SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT)
TABLE 145 SOUTH AMERICA: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION)
TABLE 146 SOUTH AMERICA: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION)
TABLE 147 SOUTH AMERICA: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION)
TABLE 148 SOUTH AMERICA: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION)
TABLE 149 SOUTH AMERICA: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION)
TABLE 150 SOUTH AMERICA: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION)
TABLE 151 SOUTH AMERICA: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION)
TABLE 152 SOUTH AMERICA: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION)
TABLE 153 BRAZIL: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 154 BRAZIL: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
TABLE 155 ARGENTINA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 156 ARGENTINA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
TABLE 157 REST OF SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 158 REST OF SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
TABLE 159 ROW: PROBIOTICS MARKET, BY REGION, 2020–2023 (USD BILLION)
TABLE 160 ROW: PROBIOTICS MARKET, BY REGION, 2024–2029 (USD BILLION)
TABLE 161 ROW: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION)
TABLE 162 ROW: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION)
TABLE 163 ROW: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT)
TABLE 164 ROW: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT)
TABLE 165 ROW: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION)
TABLE 166 ROW: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION)
TABLE 167 ROW: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION)
TABLE 168 ROW: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION)
TABLE 169 ROW: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION)
TABLE 170 ROW: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION)
TABLE 171 ROW: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION)
TABLE 172 ROW: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION)
TABLE 173 MIDDLE EAST: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 174 MIDDLE EAST: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
TABLE 175 AFRICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 176 AFRICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
TABLE 177 STRATEGIES ADOPTED BY KEY PLAYERS IN PROBIOTICS MARKET
TABLE 178 PROBIOTICS MARKET: DEGREE OF COMPETITION
TABLE 179 PROBIOTICS MARKET: PRODUCT TYPE FOOTPRINT
TABLE 180 PROBIOTICS MARKET: END USER FOOTPRINT
TABLE 181 PROBIOTICS MARKET: REGION FOOTPRINT
TABLE 182 PROBIOTICS MARKET: KEY STARTUP/SMES, 2023
TABLE 183 PROBIOTICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES
TABLE 184 PROBIOTICS MARKET: PRODUCT LAUNCHES, JANUARY 2019–FEBRUARY 2024
TABLE 185 PROBIOTICS MARKET: DEALS, JANUARY 2019–FEBRUARY 2024
TABLE 186 PROBIOTICS MARKET: EXPANSIONS, JANUARY 2019–FEBRUARY 2024
TABLE 187 PROBIOTICS MARKET: OTHERS, JANUARY 2019–FEBRUARY 2024
TABLE 188 PROBI: BUSINESS OVERVIEW
TABLE 189 PROBI: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 190 PROBI: PRODUCT LAUNCHES
TABLE 191 PROBI: DEALS
TABLE 192 NESTLÉ: BUSINESS OVERVIEW
TABLE 193 NESTLÉ: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 194 NESTLÉ: PRODUCT LAUNCHES
TABLE 195 NESTLÉ: DEALS
TABLE 196 ADM: BUSINESS OVERVIEW
TABLE 197 ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 198 ADM: DEALS
TABLE 199 ADM: EXPANSIONS
TABLE 200 DANONE: BUSINESS OVERVIEW
TABLE 201 DANONE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 202 DANONE: PRODUCT LAUNCHES
TABLE 203 DANONE: EXPANSIONS
TABLE 204 INTERNATIONAL FLAVORS & FRAGRANCES INC.: BUSINESS OVERVIEW
TABLE 205 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 206 INTERNATIONAL FLAVORS & FRAGRANCES INC.: DEALS
TABLE 207 INTERNATIONAL FLAVORS & FRAGRANCES INC.: EXPANSIONS
TABLE 208 YAKULT HONSHA CO., LTD.: BUSINESS OVERVIEW
TABLE 209 YAKULT HONSHA CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 210 YAKULT HONSHA CO., LTD.: PRODUCT LAUNCHES
TABLE 211 YAKULT HONSHA CO., LTD.: DEALS
TABLE 212 YAKULT HONSHA CO., LTD.: EXPANSIONS
TABLE 213 BIOGAIA: BUSINESS OVERVIEW
TABLE 214 BIOGAIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 215 BIOGAIA: PRODUCT LAUNCHES
TABLE 216 BIOGAIA: DEALS
TABLE 217 BIOGAIA: EXPANSIONS
TABLE 218 MORINAGA MILK INDUSTRY CO., LTD.: BUSINESS OVERVIEW
TABLE 219 MORINAGA MILK INDUSTRY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 220 MORINAGA MILK INDUSTRY CO., LTD.: PRODUCT LAUNCHES
TABLE 221 MORINAGA MILK INDUSTRY CO., LTD.: OTHERS
TABLE 222 MORINAGA MILK INDUSTRY CO., LTD.: EXPANSIONS
TABLE 223 MEIJI HOLDINGS CO., LTD.: BUSINESS OVERVIEW
TABLE 224 MEIJI HOLDINGS CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 225 LIFEWAY FOODS, INC.: BUSINESS OVERVIEW
TABLE 226 LIFEWAY FOODS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 227 LIFEWAY FOODS, INC.: DEALS
TABLE 228 ADISSEO: BUSINESS OVERVIEW
TABLE 229 ADISSEO: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 230 WINCLOVE PROBIOTICS: BUSINESS OVERVIEW
TABLE 231 WINCLOVE PROBIOTICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 232 WINCLOVE PROBIOTICS: DEALS
TABLE 233 WINCLOVE PROBIOTICS: EXPANSIONS
TABLE 234 AB-BIOTICS, S.A.: BUSINESS OVERVIEW
TABLE 235 AB-BIOTICS, S.A.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 236 AB-BIOTICS, S.A.: DEALS
TABLE 237 APSEN FARMACÊUTICA: BUSINESS OVERVIEW
TABLE 238 APSEN FARMACÊUTICA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 239 APSEN FARMACÊUTICA: PRODUCT LAUNCHES
TABLE 240 APSEN FARMACÊUTICA: DEALS
TABLE 241 LALLEMAND: BUSINESS OVERVIEW
TABLE 242 LALLEMAND: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 243 LALLEMAND: DEALS
TABLE 244 LALLEMAND: EXPANSIONS
TABLE 245 ELANCO: BUSINESS OVERVIEW
TABLE 246 ELANCO: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 247 NEXTFOODS, INC.: BUSINESS OVERVIEW
TABLE 248 NEXTFOODS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 249 NEXTFOODS, INC.: DEALS
TABLE 250 I-HEALTH, INC.: BUSINESS OVERVIEW
TABLE 251 I-HEALTH, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 252 SUJA LIFE, LLC.: BUSINESS OVERVIEW
TABLE 253 SUJA LIFE, LLC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 254 SUJA LIFE, LLC.: DEALS
TABLE 255 RENEW LIFE FORMULAS, LLC.: BUSINESS OVERVIEW
TABLE 256 RENEW LIFE FORMULAS, LLC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 257 BIOHM HEALTH: BUSINESS OVERVIEW
TABLE 258 SUN GENOMICS: BUSINESS OVERVIEW
TABLE 259 UNIQUE BIOTECH LTD: BUSINESS OVERVIEW
TABLE 260 SO GOOD SO YOU: BUSINESS OVERVIEW
TABLE 261 PROTOCOL FOR LIFE BALANCE: BUSINESS OVERVIEW
TABLE 262 ADJACENT MARKETS TO PROBIOTICS
TABLE 263 DIETARY SUPPLEMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 264 DIETARY SUPPLEMENTS MARKET, BY TYPE, 2023–2028 (USD MILLION)
TABLE 265 BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
TABLE 266 BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)
 
  
LIST OF FIGURES (87 Figure) 
 
FIGURE 1 PROBIOTICS MARKET SEGMENTATION
FIGURE 2 PROBIOTICS MARKET SEGMENTATION, BY REGION
FIGURE 3 STUDY PERIODS CONSIDERED
FIGURE 4 PROBIOTICS MARKET: RESEARCH DESIGN
FIGURE 5 KEY DATA FROM SECONDARY SOURCES
FIGURE 6 KEY INSIGHTS FROM PRIMARY SOURCES
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 8 PROBIOTICS MARKET: BOTTOM-UP APPROACH
FIGURE 9 PROBIOTICS MARKET SIZE CALCULATION STEPS AND THEIR CORRESPONDING SOURCES: SUPPLY SIDE
FIGURE 10 PROBIOTICS MARKET: TOP-DOWN APPROACH
FIGURE 11 DATA TRIANGULATION
FIGURE 12 RESEARCH LIMITATIONS & ASSOCIATED RISKS
FIGURE 13 INDICATORS OF RECESSION
FIGURE 14 GLOBAL INFLATION RATE, 2011–2022
FIGURE 15 GLOBAL GDP, 2011–2022 (USD TRILLION)
FIGURE 16 RECESSION INDICATORS AND THEIR IMPACT ON PROBIOTICS MARKET
FIGURE 17 PROBIOTICS MARKET: EARLIER FORECAST VS RECESSION IMPACT  FORECAST, 2024
FIGURE 18 PROBIOTICS MARKET, BY INGREDIENT, 2024 VS. 2029 (USD BILLION)
FIGURE 19 PROBIOTICS MARKET, BY PRODUCT TYPE, 2024 VS. 2029 (USD BILLION)
FIGURE 20 PROBIOTICS MARKET, BY END USER, 2024 VS. 2029 (USD BILLION)
FIGURE 21 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024 VS. 2029 (USD BILLION)
FIGURE 22 PROBIOTICS MARKET SHARE (VALUE), BY REGION, 2023
FIGURE 23 HEALTH BENEFITS ASSOCIATED WITH PROBIOTIC-FORTIFIED FOODS & BEVERAGES TO PROPEL MARKET
FIGURE 24 CHINA AND FUNCTIONAL FOOD & BEVERAGES TO ACCOUNT FOR LARGEST SEGMENTAL SHARES IN ASIA PACIFIC PROBIOTICS MARKET IN 2023
FIGURE 25 FUNCTIONAL FOOD & BEVERAGES SEGMENT TO DOMINATE AMONG PROBIOTIC PRODUCT TYPES IN MARKET DURING FORECAST PERIOD
FIGURE 26 DAIRY PRODUCTS TO HAVE SUBSTANTIAL LEAD OVER OTHER FUNCTIONAL FOOD & BEVERAGES WITH PROBIOTICS DURING FORECAST PERIOD
FIGURE 27 HYPERMARKETS & SUPERMARKETS TO BE LEADING DISTRIBUTION CHANNELS OF PROBIOTICS DURING FORECAST PERIOD
FIGURE 28 HUMAN END USE TO COMMAND LION’S SHARE OVER ANIMAL END USE OF PROBIOTICS DURING STUDY PERIOD
FIGURE 29 BACTERIAL PROBIOTICS TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 30 US: RETAIL AND FOOD SERVICE SALES, 2016–2022 (USD BILLION)
FIGURE 31 ASIA: ANNUAL GDP GROWTH RATE, BY COUNTRY, 2022
FIGURE 32 MARKET DYNAMICS
FIGURE 33 VALUE CHAIN ANALYSIS OF PROBIOTICS MARKET
FIGURE 34 SUPPLY CHAIN ANALYSIS OF PROBIOTICS MARKET
FIGURE 35 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY FUNCTIONAL FOOD & BEVERAGE PRODUCT, 2024 (USD/TON)
FIGURE 36 AVERAGE SELLING PRICE TREND, BY PRODUCT TYPE, 2021-2024 (USD/TON)
FIGURE 37 AVERAGE SELLING PRICE TREND FOR FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2022–2024 (USD/TON)
FIGURE 38 AVERAGE SELLING PRICE TREND FOR DIETARY SUPPLEMENTS, BY REGION, 2022–2024 (USD/TON)
FIGURE 39 AVERAGE SELLING PRICE TREND FOR ANIMAL FEED, BY REGION, 2022–2024 (USD/TON)
FIGURE 40 PROBIOTICS MARKET MAPPING
FIGURE 41 ECOSYSTEM MAPPING OF PROBIOTICS MARKET
FIGURE 42 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
FIGURE 43 NUMBER OF PATENTS GRANTED BETWEEN 2013 AND 2023
FIGURE 44 TOP 10 INVENTORS WITH HIGHEST NUMBER OF PATENT DOCUMENTS
FIGURE 45 PORTER’S FIVE FORCES ANALYSIS: PROBIOTICS MARKET
FIGURE 46 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR KEY PRODUCT TYPE
FIGURE 47 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS, BY PRODUCT TYPE
FIGURE 48 INVESTMENT AND FUNDING SCENARIO
FIGURE 49 PROBIOTICS MARKET, BY PRODUCT TYPE, 2024 VS. 2029 (USD BILLION)
FIGURE 50 US: PREFERRED SOURCES OF PROBIOTICS CONSUMPTION, 2022
FIGURE 51 PROBIOTICS MARKET, BY INGREDIENT, 2024 VS. 2029 (USD BILLION)
FIGURE 52 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024 VS. 2029 (USD BILLION)
FIGURE 53 HUMAN CONSUMPTION TO DOMINATE MARKET FROM 2024 TO 2029 (USD BILLION)
FIGURE 54 FREQUENCY OF PROBIOTIC CONSUMPTION AMONG USERS
FIGURE 55 RAPIDLY GROWING MARKETS TO EMERGE AS NEW HOT SPOTS
FIGURE 56 NORTH AMERICA: INFLATION DATA, BY KEY COUNTRY, 2017–2022
FIGURE 57 NORTH AMERICA: RECESSION IMPACT ANALYSIS
FIGURE 58 EUROPE: MARKET SNAPSHOT
FIGURE 59 EUROPE: INFLATION DATA, BY KEY COUNTRY, 2017–2022
FIGURE 60 EUROPE: RECESSION IMPACT ANALYSIS
FIGURE 61 ASIA PACIFIC: MARKET SNAPSHOT
FIGURE 62 ASIA PACIFIC: INFLATION DATA, BY KEY COUNTRY, 2017–2022
FIGURE 63 ASIA PACIFIC: RECESSION IMPACT ANALYSIS
FIGURE 64 SOUTH AMERICA: INFLATION DATA, BY COUNTRY, 2017–2022
FIGURE 65 SOUTH AMERICA: RECESSION IMPACT ANALYSIS
FIGURE 66 ROW: INFLATION DATA, BY SUBREGION, 2017–2022
FIGURE 67 ROW: RECESSION IMPACT ANALYSIS
FIGURE 68 REVENUE ANALYSIS OF KEY MARKET PLAYERS, 2020–2022 (USD BILLION)
FIGURE 69 MARKET SHARE OF LEADING COMPANIES IN PROBIOTICS MARKET (GLOBAL), 2023
FIGURE 70 PROBIOTICS MARKET: COMPANY VALUATION (USD BILLION)
FIGURE 71 PROBIOTICS MARKET: EV/EBITDA, 2022 (USD BILLION)
FIGURE 72 PROBIOTICS MARKET: BRAND/PRODUCT COMPARISON
FIGURE 73 PROBIOTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 74 PROBIOTICS MARKET: COMPANY FOOTPRINT, 2023
FIGURE 75 PROBIOTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 76 PROBI: COMPANY SNAPSHOT
FIGURE 77 NESTLÉ: COMPANY SNAPSHOT
FIGURE 78 ADM: COMPANY SNAPSHOT
FIGURE 79 DANONE: COMPANY SNAPSHOT
FIGURE 80 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT
FIGURE 81 YAKULT HONSHA CO., LTD.: COMPANY SNAPSHOT
FIGURE 82 BIOGAIA: COMPANY SNAPSHOT
FIGURE 83 MORINAGA MILK INDUSTRY CO., LTD.: COMPANY SNAPSHOT
FIGURE 84 MEIJI HOLDINGS CO., LTD.: COMPANY SNAPSHOT
FIGURE 85 LIFEWAY FOODS, INC.: COMPANY SNAPSHOT
FIGURE 86 ADISSEO: COMPANY SNAPSHOT
FIGURE 87 ELANCO: COMPANY SNAPSHOT

 

This research involves the extensive use of secondary sources; directories; and databases (Bloomberg and Factiva) to identify and collect information useful for a technical, market-oriented, and commercial study of the Probiotics market. In-depth interviews were conducted with various primary respondents, such as key industry participants, Subject Matter Experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess prospects.

Secondary Research

In the secondary research process, various sources, such as the Food and Agricultural Organization (FAO), United States Department of Agriculture (USDA), U.S. Food and Drug Administration (FDA) U.S. Food and Drug Administration (FDA), European Food Safety Authority (EFSA), World Health Organization (WHO), Consumer Healthcare Products Association (CHPA), European Federation of Associations of Health Product Manufacturers (EHPM), Canadian Health Food Association (CHFA), and Health Food Manufacturers' Association (HFMA), associations were referred to identify and collect information for this study. The secondary sources also include journals, press releases, investor presentations of companies, whitepapers, certified publications, articles by recognized authors and regulatory bodies, trade directories, and paid databases.

Primary Research

The Probiotics market encompasses various stakeholders involved in the supply chain, raw material manufacturers, raw material suppliers, regulatory organizations, and research institutions. To gather comprehensive information, primary sources from both the supply and demand sides were engaged. Primary interviewees from the supply side consisted of manufacturers, distributors, importers, and technology providers involved in the production and distribution of Probiotics. On the demand side, key opinion leaders, executives, and CEOs of companies in the Probiotics industry were approached through questionnaires, emails, and telephonic interviews. This approach ensured a comprehensive and well-rounded understanding of the Probiotics market from various perspectives.

Probiotics Market Growth

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were used to estimate and validate the market’s and various dependent submarkets’ size. The research methodology used to estimate the market size includes extensive secondary research of key players, reports, reviews, and newsletters of top market players, along with extensive interviews from leaders, such as CEOs, directors, and marketing executives.

Global Probiotics Market Size: Top-Down Approach

Probiotics Market Size Top Down Approach

Probiotics Market Segment Top Down Approach

To know about the assumptions considered for the study, Request for Free Sample Report

Global Probiotics Market: Data Triangluation

After arriving at the overall size from the market size estimation process explained above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures explained below were implemented, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for various market segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size was validated using both the top-down and bottom-up approaches.

Probiotics Market Data Triangluation

Market Definition

The joint Food and Agriculture Organization (FAO)/World Health Organization (WHO) working group defines probiotics as “live micro-organisms, which when administered in adequate amounts confer a health benefit on the host” (FAO/ WHO, 2001).

Probiotics are living microorganisms that have been shown to provide specific health benefits to consumers. They are known to support gut health and help in running the digestive system smoothly. Yogurt is one of the prime natural sources of probiotics.

According to the National Center for Complementary and Integrative Health, “Probiotics are live microorganisms that are intended to have health benefits when consumed or applied to the body.” The major function of probiotics is to maintain a healthy balance in the body. Several types of microorganisms are present in probiotics, and they may have different effects on the body. The most common bacteria belong to the group called Lactobacillus and Bifidobacterium.

Key Stakeholders

  • Manufacturers, Importers and Exporters, Traders, Distributors, and Suppliers of Probiotics
  • Nutraceutical Manufacturers
  • Food Processors and Manufacturers
  • Government and Research Organizations
  • Trade Associations and Industry Bodies
  • Regulatory bodies and associations are as follows:
    • Food Agriculture Organization (FAO)
    • World Health Organization (WHO)
    • International Dairy Federation (IDF)
    • European Food & Feed Cultures Association (EFFCA)
    • National Yogurt Association (NYA)
    • International Scientific Association for Probiotics and Prebiotics (ISAPP)
    • International Probiotics Association (IPA)
    • Council for Responsible Nutrition (CRN)
    • National Yogurt Association (NYA)
    • International Frozen Yogurt Association (IFYA)
    • American Nutrition Association (ANA)

Report Objectives

  • To define, segment, and project the global market for Probiotics on the basis of product type, ingredient, distribution channel, end user, and region 
  • To provide detailed information regarding the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze the micro markets with respect to individual growth trends, future prospects, and their contribution to the total market
  • To analyze the opportunities in the market for stakeholders and provide a competitive landscape of the market leaders
  • To project the size of the market and its submarkets, in terms of value with respect to the regions (along with the key countries)
  • To strategically profile the key players and comprehensively analyze their market position and core competencies
  • To analyze competitive developments in the Probiotics market, including joint ventures, mergers & acquisitions, new product developments, and research & development activities

Available Customizations:

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

The following customization options are available for the report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolio of each company

Geographic Analysis

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

  • Further breakdown of the Rest of the European Probiotics market, by key country
  • Further breakdown of the Rest of the Asia Pacific Probiotics market, by key country
  • Further breakdown of the Rest of South America Probiotics market, by key country

Company Information

  • Detailed analyses and profiling of additional market players
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
FB 2269
Published ON
Mar, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Probiotics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
Website Feedback